Insulin therapy reduces microvascular risk in T1DM patients (Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group, 2002). The gene discussed is INS; the disease is type 1 diabetes mellitus.